Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Antihypertensive Drugs Market Size study, by Therapeutic Class (Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2020-2027

  • BIZ3921545
  • 200 Pages
  • June 2020
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Antihypertensive Drugs Market is valued at approximately USD 23.2 million in 2019 and is anticipated to grow with a healthy growth rate of more than 3.1% over the forecast period 2020-2027. Antihypertensive drug is the class of drug used in the treatment of hypertension (high blood pressure). Hypertension is one of the leading causes of heart complications, such as heart failure, heart attack, and dementia. Thus, the treatment of hypertension must be integrated into an overall program to manage factors that intensify the risk of cardiovascular events (such as stroke and myocardial infarction). Therefore, there are a variety of antihypertensive drugs has been developed for treating hypertension. Some of the major antihypertensive drugs are thiazide diuretics, beta-adrenoceptor antagonists (beta-blockers), dihydropyridine calcium-channel blockers, and many more. These drugs can reduce the blood pressure rates and can prevent the health complications associated with high blood pressure. Therefore, these factors are anticipated to accelerate the market growth around the world. Moreover, the rise in cases of hypertension across the globe, followed by the growing elderly population are few other factors responsible for the market growth over the forecast period. According to the World Health Organization (WHO), around 1.3 billion people have hypertension around the world. Also, the possibility of its prevalence increases with age. As per the Framingham Heart Study, hypertension eventually developed in over 90% of participants with normal blood pressure at 55 years of age. By age 60 years of age, nearly 60% of the population has hypertension, by 70 years, about 65% of men and 75% of women have hypertension. This, in turn, is likely to accelerate the demand for drugs all over the world. Recently, the COVID-19 is widely spread throughout the world, thus various regional governments are mandating the use of drugs among the patients to prevent or mitigate the risk of respiratory-related problems. This is likely to strengthen the usage for antihypertensive drugs that encourage the manufacturers to produce them thereby, the market would grow at a significant rate in the forthcoming years. However, side-effects related to the use of drugs is one of the major factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Antihypertensive Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to rise in prevalence of hypertension, along with the significant initiatives opt by the market players in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising geriatric population and increasing incidences of heart attack and failures among people would create lucrative growth prospects for the Antihypertensive Drugs market across the Asia-Pacific region.

Major market player included in this report are:

Boehringer Ingelheim International GmbH

Merck & Co., KGaA

Johnson and Johnson

Bayer AG

Pfizer, Inc.

Takeda Pharmaceutical Co. Ltd.

AstraZeneca plc

Daiichi Sankyo Company, Ltd.

Sanofi S.A.

Novartis International AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapeutic Class:

Diuretics

Angiotensin-Converting Enzyme (ACE) Inhibitors

Calcium Channel Blockers

Vasodilators

Beta-adrenergic Blockers

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global Antihypertensive Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)

1.2.1. Antihypertensive Drugs Market, by Region, 2018-2027 (USD Million)

1.2.2. Antihypertensive Drugs Market, by Therapeutic Class, 2018-2027 (USD Million)

1.2.3. Antihypertensive Drugs Market, by Distribution Channel, 2018-2027 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Antihypertensive Drugs Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Antihypertensive Drugs Market Dynamics

3.1. Antihypertensive Drugs Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Antihypertensive Drugs Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Antihypertensive Drugs Market, by Therapeutic Class

5.1. Market Snapshot

5.2. Global Antihypertensive Drugs Market by Therapeutic Class, Performance - Potential Analysis

5.3. Global Antihypertensive Drugs Market Estimates & Forecasts by Therapeutic Class 2017-2027 (USD Million)

5.4. Antihypertensive Drugs Market, Sub Segment Analysis

5.4.1. Diuretics

5.4.2. Angiotensin-Converting Enzyme (ACE) Inhibitors

5.4.3. Calcium Channel Blockers

5.4.4. Vasodilators

5.4.5. Beta-adrenergic Blockers

5.4.6. Others

Chapter 6. Global Antihypertensive Drugs Market, by Distribution Channel

6.1. Market Snapshot

6.2. Global Antihypertensive Drugs Market by Distribution Channel, Performance - Potential Analysis

6.3. Global Antihypertensive Drugs Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Million)

6.4. Antihypertensive Drugs Market, Sub Segment Analysis

6.4.1. Hospital Pharmacies

6.4.2. Retail Pharmacies

6.4.3. Online Pharmacies

Chapter 7. Global Antihypertensive Drugs Market, Regional Analysis

7.1. Antihypertensive Drugs Market, Regional Market Snapshot

7.2. North America Antihypertensive Drugs Market

7.2.1. U.S. Antihypertensive Drugs Market

7.2.1.1. Therapeutic Class breakdown estimates & forecasts, 2017-2027

7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027

7.2.2. Canada Antihypertensive Drugs Market

7.3. Europe Antihypertensive Drugs Market Snapshot

7.3.1. U.K. Antihypertensive Drugs Market

7.3.2. Germany Antihypertensive Drugs Market

7.3.3. France Antihypertensive Drugs Market

7.3.4. Spain Antihypertensive Drugs Market

7.3.5. Italy Antihypertensive Drugs Market

7.3.6. Rest of Europe Antihypertensive Drugs Market

7.4. Asia-Pacific Antihypertensive Drugs Market Snapshot

7.4.1. China Antihypertensive Drugs Market

7.4.2. India Antihypertensive Drugs Market

7.4.3. Japan Antihypertensive Drugs Market

7.4.4. Australia Antihypertensive Drugs Market

7.4.5. South Korea Antihypertensive Drugs Market

7.4.6. Rest of Asia Pacific Antihypertensive Drugs Market

7.5. Latin America Antihypertensive Drugs Market Snapshot

7.5.1. Brazil Antihypertensive Drugs Market

7.5.2. Mexico Antihypertensive Drugs Market

7.6. Rest of The World Antihypertensive Drugs Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Boehringer Ingelheim International GmbH

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. Merck & Co., KGaA

8.2.3. Johnson and Johnson

8.2.4. Bayer AG

8.2.5. Pfizer, Inc.

8.2.6. Takeda Pharmaceutical Co. Ltd.

8.2.7. AstraZeneca plc

8.2.8. Daiichi Sankyo Company, Ltd.

8.2.9. Sanofi S.A.

8.2.10. Novartis International AG

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Antihypertensive Drugs market, report scope

TABLE 2. Global Antihypertensive Drugs market estimates & forecasts by region 2017-2027 (USD Million)

TABLE 3. Global Antihypertensive Drugs market estimates & forecasts by Therapeutic Class 2017-2027 (USD Million)

TABLE 4. Global Antihypertensive Drugs market estimates & forecasts by Distribution Channel 2017-2027 (USD Million)

TABLE 5. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 6. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 7. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 8. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 9. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 10. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 11. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 12. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 13. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 14. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 15. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 16. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 17. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 18. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 19. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 20. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 21. U.S. Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 22. U.S. Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 23. U.S. Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 24. Canada Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 25. Canada Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 26. Canada Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 27. UK Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 28. UK Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 29. UK Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 30. Germany Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 31. Germany Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 32. Germany Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 33. France Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 34. France Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 35. France Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 36. Spain Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 37. Spain Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 38. Spain Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 39. Italy Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 40. Italy Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 41. Italy Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 42. ROE Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 43. ROE Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 44. ROE Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 45. China Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 46. China Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 47. China Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 48. India Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 49. India Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 50. India Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 51. Japan Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 52. Japan Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 53. Japan Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 54. Australia Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 55. Australia Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 56. Australia Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 57. South Korea Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 58. South Korea Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 59. South Korea Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 60. ROPAC Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 61. ROPAC Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 62. ROPAC Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 63. Brazil Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 64. Brazil Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 65. Brazil Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 66. Mexico Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 67. Mexico Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 68. Mexico Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 69. ROLA Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 70. ROLA Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 71. ROLA Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 72. ROW Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)

TABLE 73. ROW Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 74. ROW Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 75. List of secondary sources, used in the study of global Antihypertensive Drugs market

TABLE 76. List of primary sources, used in the study of global Antihypertensive Drugs market

TABLE 77. Years considered for the study

TABLE 78. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
View Details
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
View Details
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research